Nordhealth Achieves EBITDA - CAPEX Breakeven Ahead of Schedule
Helsinki, Finland - July 18, 2024 - Nordhealth is pleased to announce that it has achieved EBITDA-CAPEX breakeven in Q2 2024, excluding one-off, non-recurring items. This milestone, initially projected for Q1 2025 as outlined in the Q4 2023 Investor Presentation on March 5, 2024, and reaffirmed in the 2023 Annual Report on April 12, 2024, has been reached ahead of schedule. Preliminary figures indicate that Nordhealth's EBITDA-CAPEX, excluding one-off, non-recurring items, will be slightly positive in Q2 2024. However, as planned, the company does not expect to maintain EBITDA-CAPEX